.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Chinese Patent Office
Express Scripts
Deloitte
Healthtrust
Dow
Johnson and Johnson
Fish and Richardson
Merck

Generated: December 16, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Denmark Patent: 685/96

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novo Nordisk IncNOVOLOGinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-001Jun 7, 2000RXYesYes► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG FLEXPENinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-003Jan 19, 2001RXYesYes► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG FLEXTOUCHinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-005Oct 31, 2013RXYesYes► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG INNOLETinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-004Apr 23, 2004DISCNNoNo► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG MIX 50/50insulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021810-001Aug 26, 2008DISCNNoNo► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG MIX 70/30insulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021172-001Nov 1, 2001RXYesYes► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG MIX 70/30 FLEXPENinsulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021172-004May 3, 2002RXYesYes► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG MIX 70/30 PENFILLinsulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021172-002Nov 1, 2001DISCNNoNo► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG MIX 70/30 PENFILLinsulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021172-003Nov 1, 2001DISCNNoNo► Subscribe► SubscribeY
Novo Nordisk IncNOVOLOG PENFILLinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-002Jun 7, 2000RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist